Godavari Biorefineries Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release for Q3 9M FY 26".
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Biorefineries reported Q3 FY26 total income of Rs 461.9 crore, up 2.5% YoY, with EBITDA rising 13.8% to Rs 45.1 crore and profit before tax (before exceptional items) surging 152% to Rs 21.4 crore. EBITDA margin expanded by 97 basis points to 9.8%, driven by operating leverage and a shift toward high-margin segments. For 9M FY26, the company turned around from a loss, posting EBITDA of Rs 47.2 crore versus a Rs 1.4 crore loss in the prior year period. Bio-based chemicals segment EBITDA grew 76.7% YoY in Q3, while sugar & cogeneration grew 28.1%; ethanol segment EBITDA fell 56.6%. Notable developments include a U.S. patent for an anti-cancer molecule, a collaboration with Synthomer for bio-based butyl acrylate, and the Jivana consumer brand crossing Rs 100 crore in revenue during 9M FY26.
The sharp improvement in profitability, margin expansion, and 46% drop in finance costs signal strengthening business fundamentals. Shareholders may view the turnaround in 9M FY26 and the upcoming grain-based ethanol capacity commissioning in Q1 FY27 as positive drivers, though the Rs 7.9 crore exceptional charge from new labor laws is a one-time headwind to watch.